Determining the Optimal Examined Lymph Node for Accurate Staging and Long-term Survival in Rectal Cancer

The Second Affiliated Hospital of Harbin Medical University7,694 enrolled

Overview

A multi-institutional registry of collected data on patients with rectal cancer who underwent surgical resection between January 2009 and December 2018 at the departments of colorectal surgery of five medical institutions in China (National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; Changhai Hospital, Naval Medical University; The Second Affiliated Hospital of Harbin Medical University; The Affiliated Tumor Hospital of Harbin Medical University; The Affiliated Tumor Hospital of Guangxi Medical University)

Study Type

OBSERVATIONAL

Enrollment

7,694

Conditions

Rectal Cancer

Interventions

lymph node numberPROCEDURE

Lymph nodes were harvested during surgical resection of rectal cancer

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Rectal cancer patients in stage I-III who underwent surgical resection for first primary rectal cancer with at least one lymph node were eligible Exclusion Criteria: * Patients with missing values on lymph node count and clinical features were excluded

Outcomes

Primary Outcomes

lymph node number

lymph nodes were harvested during surgical resection of rectal cancer

Time frame: during the surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.